Caisse De Depot Et Placement Du Quebec Amgen Inc Transaction History

Caisse De Depot Et Placement Du Quebec

$50.2 Billion
Q3 2024

A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Amgen Inc stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 293,333 shares of AMGN stock, worth $77.3 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

293,333

Previous 178,123 64.68%

Holding current value

$77.3 Million

Previous $55.7 Million 69.82%

% of portfolio

0.19%

Previous 0.14%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $35.6 Million - $38.9 Million	115,210 Added 64.68%	293,333 $94.5 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $11.8 Million - $14.3 Million	-44,782 Reduced 20.09%	178,123 $55.7 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $7.05 Million - $8.51 Million	26,221 Added 13.33%	222,905 $63.4 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $45.9 Million - $51.8 Million	179,429 Added 1039.87%	196,684 $56.6 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $1.88 Million - $2.33 Million	-8,600 Reduced 33.26%	17,255 $4.64 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $1.49 Million - $1.76 Million	-6,962 Reduced 21.21%	25,855 $5.74 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $3.68 Million - $4.49 Million	-16,319 Reduced 33.21%	32,817 $7.93 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $14.5 Million - $18.4 Million	-63,100 Reduced 56.22%	49,136 $12.9 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $16.2 Million - $18.3 Million	72,336 Added 181.29%	112,236 $25.3 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $1.15 Million - $1.28 Million	-5,000 Reduced 11.14%	39,900 $9.71 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $9.6 Million - $10.6 Million	43,800 Added 3981.82%	44,900 $10.9 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $8.35 Million - $9.26 Million	-35,748 Reduced 97.01%	1,100 $268,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $1.03 Million - $1.2 Million	-4,641 Reduced 11.19%	36,848 $9.17 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $1.08 Million - $1.29 Million	-4,994 Reduced 10.74%	41,489 $9.54 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $1.27 Million - $1.41 Million	-5,400 Reduced 10.41%	46,483 $11.8 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $16.2 Million - $19.9 Million	-81,800 Reduced 61.19%	51,883 $12.2 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $12.8 Million - $16.9 Million	70,006 Added 109.94%	133,683 $27.1 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $12.3 Million - $15.8 Million	-64,806 Reduced 50.44%	63,677 $15.4 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $9.75 Million - $11.7 Million	-56,000 Reduced 30.36%	128,483 $24.9 Million
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $12.8 Million - $15 Million	76,756 Added 71.25%	184,483 $34 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $10.3 Million - $11.6 Million	-56,856 Reduced 34.55%	107,727 $20.5 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $14.7 Million - $17.1 Million	82,300 Added 100.02%	164,583 $32 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $12.9 Million - $14.6 Million	-69,800 Reduced 45.9%	82,283 $17.1 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $32,711 - $36,742	-197 Reduced 0.13%	152,083 $28.1 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $45.7 Million - $53.5 Million	-269,953 Reduced 63.93%	152,280 $26 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $11.9 Million - $13.3 Million	70,730 Added 20.12%	422,233 $73.4 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $58.8 Million - $67.1 Million	351,503	351,503 $65.8 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.

Account

Caisse De Depot Et Placement Du Quebec Amgen Inc Transaction History